Effect of Music Therapy on Patients Undergoing Intravitreal Injections

• Sponsor: Yale University (Other)
• Overall Status: Completed
• CT.gov ID: NCT00702039
• Collaborator: (none)
• Enrollment: 50
• Location: 1
• Duration (Months): 51.9
• Patients Per Site Per Month: 1

Study Details

Study Description

Brief Summary

Multiple studies in various specialties, including ophthalmology, are reported in the literature that show that playing music during a procedure (dubbed music therapy) increases patient satisfaction and may reduce patient anxiety and stress levels.

There is no study in the literature that assesses the effects of listening to music in patients undergoing intravitreal injections. This study aims to assess whether listening to music improves patient satisfaction or reduces their anxiety levels in subjects undergoing intravitreal injections.

Condition or Disease	Intervention/Treatment	Phase
Intravitreal Injections; Patient Satisfaction; Patient Anxiety	Other: No Music; Other: Music Therapy

Study Design

• Study Type: Observational
• Actual Enrollment: 50 participants
• Observational Model: Case-Control
• Time Perspective: Prospective
• Official Title: Effect of Music Therapy on Patients Undergoing Intravitreal Injections
• Study Start Date: Feb 1, 2007
• Actual Primary Completion Date: Feb 1, 2009
• Actual Study Completion Date: Jun 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
1 Those patients receiving intravitreal injections who will be listening to classical music during injection.	Other: Music Therapy; Classical music being played during intravitreal injection.
2 Those patients receiving intravitreal injections who will not be listening to any music during injection.	Other: No Music; No music will be played in patients in arm 2 of the study.

Outcome Measures

Primary Outcome Measures

1. This study aims to assess what affects music therapy has on patients receiving intravitreal injections. The subject will take a Satisfaction Survey after the procedure and an Anxiety Survey before and after the injection. [Before and after the subject's intravitreal injection.]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Those patients at least 18 years old already scheduled for intravitreal injections.

Exclusion Criteria:

• Those patients not interested in participating in the study or not capable of filling out the questionnaire secondary to limited mental capability.

• Non- English speaking subjects will be excluded from the study.

• Those patients that participated in the study will not be allowed to participate a second time.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Yale Eye Center	New Haven	Connecticut	United States	06510

Sponsors and Collaborators

• Yale University

Investigators

• Principal Investigator: Ron Adelman, MD, Yale University Department of Ophthalmology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Yale University
• ClinicalTrials.gov Identifier: NCT00702039
• Other Study ID Numbers: 0702002303
• First Posted: Jun 19, 2008
• Last Update Posted: Jan 17, 2018
• Last Verified: Jan 1, 2018

Study Results

No Results Posted as of Jan 17, 2018